MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study (Q40556782)

21 September 2017

MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study (English)

1 reference

21 September 2017

0 references

1 reference

Giuseppe Matullo

3

0 references

Casper G. Schalkwijk

6

object named as

Casper Schalkwijk

1 reference

21 September 2017

Federica Barutta

1

1 reference

21 September 2017

Graziella Bruno

2

1 reference

21 September 2017

Nish Chaturvedi

4

1 reference

21 September 2017

Serena Grimaldi

5

1 reference

21 September 2017

Coen D Stehouwer

7

1 reference

21 September 2017

John H Fuller

8

1 reference

21 September 2017

Gabriella Gruden

9

1 reference

21 September 2017

1 October 2016

1 reference

21 September 2017

1 reference

21 September 2017

54

1 reference

21 September 2017

133-139

1 reference

21 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00592-016-0915-4

21 September 2017

0 references

cites work

MicroRNAs: small RNAs with a big role in gene regulation

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

β-Cell MicroRNAs: Small but Powerful

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Noncoding RNAs in diabetes vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Role of microRNAs in diabetes and its cardiovascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Circulating MicroRNAs in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Urinary exosomal microRNAs in incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Circulating microRNAs in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

SDF-1 is both necessary and sufficient to promote proliferative retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

MicroRNAs in platelet function and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

The Role of microRNA-126 in Vascular Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1+/Lin− progenitor cells in ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-016-0915-4

10.1007/S00592-016-0915-4

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference